Literature DB >> 33780028

Monitoring of patients with paroxysmal nocturnal hemoglobinuria on a complement inhibitor.

Austin G Kulasekararaj1, Robert A Brodsky2, Anita Hill3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33780028     DOI： 10.1002/ajh.26176

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study.

Authors:  Jamile Shammo; Ajeet Gajra; Yogesh Patel; Ioannis Tomazos; Jonathan Kish; Anita Hill; J Rafael Sierra; David Araten
Journal:  J Blood Med       Date:  2022-08-12

2.  Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Austin Kulasekararaj; Axel Glasmacher; Peng Liu; Jeff Szer; David Araten; Geraldine Rauch; Chad Gwaltney; J Rafael Sierra; Jong Wook Lee
Journal:  Eur J Haematol       Date:  2022-03-01       Impact factor: 3.674
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.